Visibly Digital Acuity Product
Digital Visual Acuity Test. 510(k) K220090, from Visibly, Inc. (Chicago, IL). Product code QTO, class 1.
As of Nov 19, 2026, K220090 is an FDA 510(k) held by Visibly, Inc., substantially equivalent on Aug 12, 2022 after 213 days, with no recalls tied to it in FDA's recall database.
- Review time: 213 days
- Recalls: 0
The Visibly Digital Acuity Product (VDAP) is a web-based, self-guided software application intended for use by adults, ages 22 to 40, who have the capability to perform a self-test at home, to aid in the evaluation of visual acuity with or without correction.
- Central Vision Analyzer Model 1000K100095 · Vimetrics,Llc. · May 10, 2010
- Solohealth StationK113402 · Solohealth, Inc. · May 30, 2012
- myVision Track Model 005K143211 · Vital Art and Science Incorporated · Mar 20, 2015
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 11, 2022
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1150
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files